Table 2.
Characteristic | Chaihu-huaji group | Control group | p |
---|---|---|---|
(n=64) | (n=61) | ||
Age (years) | 47.51 ± 10.32 | 46.36 ± 9.67 | 0.52 |
Gender | |||
Male | 52 | 51 | 0.729 |
Female | 12 | 10 | |
Number of tumors | |||
1 | 14 | 20 | 0.363 |
2 | 19 | 12 | |
3 | 19 | 15 | |
12 | 14 | ||
Main tumor size (cm) | 6.20 ± 0.85 | 6.27 ± 0.87 | 0.648 |
Child–Pugh class | |||
A | 45 | 40 | 0.57 |
B | 19 | 21 | |
KPS | |||
70 | 15 | 9 | 0.572 |
80 | 26 | 24 | |
90 | 18 | 22 | |
100 | 5 | 6 | |
Background liver disease | |||
HBV infection | 48 | 51 | 0.411 |
HCV infection | 10 | 5 | |
Others | 6 | 5 | |
Liver cirrhosis | 52 | 52 | 0.55 |
AFP level (ng/mL) | |||
11 | 8 | 0.354 | |
100-400 | 18 | 12 | |
35 | 41 | ||
Barcelona Clinic Liver Cancer stage | |||
I | 7 | 6 | 0.733 |
II | 21 | 23 | |
III | 36 | 32 |
KPS, Karnofsky performance score; HBV, hepatitis B virus; HCV, hepatitis C virus; AFP, alpha-fetoprotein.